Evaluation of binding property to tau protein, systemic pharmacokinetics and effective dose of [11C]PBB3
Not Applicable
- Conditions
- Healthy volunteer and Alzheimer's disease
- Registration Number
- JPRN-UMIN000008242
- Lead Sponsor
- ational Institute of Radiological Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1.psychiatric complications such as drug abuse 2.other organic brain complications such as symptomatic stroke, PD-related disorders and other neurodegenrative diseases 3.severe physical complications 4.subject who has metal such as pacemaker in the body, and cannot perform MRI examination 5.subjects with tattoo 6.subject with claustrophobia who cannot perform MRI examination 7.exclude the patients who are recognized as inadequate patients by doctors with resposibility in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method